Skip to main content
Open Forum Infectious Diseases logoLink to Open Forum Infectious Diseases
. 2024 Mar 6;11(3):ofae045. doi: 10.1093/ofid/ofae045

Genetic Susceptibility to Astrovirus Diarrhea in Bangladeshi Infants

Laura Chen 1,#, Rebecca M Munday 2,#, Rashidul Haque 3, Dylan Duchen 4, Uma Nayak 5,6, Poonum Korpe 7, Alexander J Mentzer 8, Beth D Kirkpatrick 9, Genevieve L Wojcik 10, William A Petri Jr 11, Priya Duggal 12,3,✉
PMCID: PMC10960603  PMID: 38524222

Abstract

Background

Astroviral infections commonly cause acute nonbacterial gastroenteritis in children globally. However, these infections often go undiagnosed outside of research settings. There is no treatment available for astrovirus, and Astroviridae strain diversity presents a challenge to potential vaccine development.

Methods

To address our hypothesis that host genetic risk factors are associated with astrovirus disease susceptibility, we performed a genome-wide association study of astrovirus infection in the first year of life from children enrolled in 2 Bangladeshi birth cohorts.

Results

We identified a novel region on chromosome 1 near the loricrin gene (LOR) associated with astrovirus diarrheal infection (rs75437404; meta-analysis P = 8.82 × 10−9; A allele odds ratio, 2.71) and on chromosome 10 near the prolactin releasing hormone receptor gene (PRLHR) (rs75935441; meta-analysis P = 1.33 × 10−8; C allele odds ratio, 4.17). The prolactin-releasing peptide has been shown to influence feeding patterns and energy balance in mice. In addition, several single-nucleotide polymorphisms in the chromosome 1 locus have previously been associated with expression of innate immune system genes PGLYRP4, S100A9, and S100A12.

Conclusions

This study identified 2 significant host genetic regions that may influence astrovirus diarrhea susceptibility and should be considered in further studies.

Keywords: Astrovirus, diarrhea, host genetics, GWAS


We identified 2 genetic polymorphisms associated with greatly increased risk of astrovirus diarrheal infections in the first year of life, the A allele of rs75437404 (odds ratio, 2.71) and the C allele of rs75935441 (odds ratio, 4.17).

Graphical Abstract

graphic file with name ofae045_ga.jpg


Diarrhea is the eighth leading cause of death across all ages and the second leading cause of death among children <5 years of age [1, 2]. There were 70.6 deaths per 100 000 children in this age group globally in 2016, compared with 1.3 deaths per 100 000 children within high-income countries [3]. Classic human astroviruses alone account for 2%–9% of all cases of acute nonbacterial gastroenteritis in children across the world, and an analysis of a Bangladeshi birth cohort found that 15%–20% of all diarrhea samples in the first year of life were positive for astrovirus [4, 5]. Astroviral infections are characterized by 2–3 days of watery diarrhea, but unlike many other enteric pathogens, astrovirus causes little histological change to intestinal epithelia, including inflammatory responses and cell death [4]. The virus can be recovered from the feces of asymptomatic children, suggesting the possibility of prolonged viral shedding or possibly a mechanism that allows astrovirus to remain in the gastrointestinal tract while causing epithelial barrier dysfunction [6–10].

Beyond gastrointestinal infections, there are reported cases of immunocompromised patients with encephalitis and meningitis, where astrovirus RNA has been detected in cerebrospinal fluid [11, 10]. Coupled with other known target organs in animals and the ability to infect across species, the burden of disease associated with astroviral infections may be higher than expected. In patients with gastroenteritis-associated astrovirus infections, the only available therapy is fluid replacement to avoid dehydration, as treatment for the virus does not exist.

Astrovirus is most commonly spread from person to person, especially via fecal-to-oral transmission and drinking water routes [12, 13]. There are 2 types of astrovirus, classic and novel, that are determined by genetic similarity; novel astroviruses are phylogenetically distant from classic human astroviruses [11]. Both classic and novel astroviruses circulate globally, with classic viruses more prevalent in developing countries [4, 10]. The persistence of astrovirus in high-income settings suggests that prevention of disease requires strategies beyond hygiene improvements [14]. Of the 3 open reading frames in the astrovirus genome, classic astroviruses share 64%–84% of capsid amino acid similarities and 93%–95% of nucleotide similarities in part of the second open reading frame [10]. Novel astroviruses belong to different clades than classic astroviruses, sharing up to 54% of amino acid identity with classic astroviruses [10]. The wide range of genetic diversity within Astroviridae makes potential vaccine development especially difficult.

We lack an understanding of the risk factors associated with astrovirus infections and disease severity. To identify host genetic risk factors associated with astrovirus disease susceptibility that may explain disease mechanism and vaccine targets, we performed genome-wide association studies in children enrolled in 2 birth cohorts, the Performance of Rotavirus and Oral Polio Vaccines in Developing Countries (PROVIDE) study and the Cryptosporidiosis and Enteropathogens in Bangladesh Birth Cohort (CBC) study in Dhaka, Bangladesh [15, 16]. We meta-analyzed the results and identified 2 novel regions on chromosomes 1 and 10 significantly associated with astrovirus diarrheal infections in infants.

METHODS

The PROVIDE study protocol was approved by the Research Review Committee and Ethics Review Committee at the International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b) and the institutional review boards of the University of Virginia and Vermont before implementation. The Ethics and Research Review Committees at icddr,b approved the CBC study. For both studies, informed written consent was obtained from the participants or the parents or guardians of all participants.

PROVIDE Study Design

The PROVIDE study, including children from the Mirpur area of Dhaka, Bangladesh, aimed to evaluate the efficacy of oral and injectable vaccines using a randomized controlled clinical trial 2 × 2 factorial design [15]. From 2011 to 2016, the 700 children in the birth cohort and their mothers were followed up for the child's first 2 years of life, with biweekly diarrhea surveillance conducted in the homes by field research assistants. Active episodes of diarrhea were referred to the study clinic for evaluation and treatment. For each episode, a diarrhea stool specimen was collected. Height-for-age z (HAZ) and weight-for-age z (WAZ) scores were collected every 3 months.

CBC Study Design

The CBC study investigated the disease burden of cryptosporidiosis and its effect on children's growth in urban and rural Bangladesh [16]. A total of 500 children from Mirpur, Dhaka, and 258 children from Mirzapur, a rural subdistrict located near Dhaka, were enrolled at birth. From 2014 to 2018, twice-weekly in-home visits were conducted by field research assistants to collect data regarding diarrhea and disease in children, and HAZ and WAZ scores were collected every 3 months. The study clinic was available to children and caregivers for development of symptoms of any illness. Stool samples were collected monthly and during episodes of diarrhea. Only a subset of children from the Mirpur site had polymerase chain reaction (PCR) testing of diarrheal samples (n = 220) and were therefore included in this study.

Case and Control Definitions

Stool samples collected in both cohorts were tested for the presence of pathogens via real-time reverse-transcription PCR (RT-PCR) using TaqMan Array Cards [17]. Bar graphs displaying the distribution of RT-PCR cycle threshold (Ct) values for astrovirus in diarrhea samples were plotted using R v3.5.1 (Supplementary Figure 1). Case patients with diarrhea attributable to astrovirus were defined as children with diarrheal samples collected within the first year of life that resulted in RT-PCR Ct values for astrovirus >0 and <30. Children were defined as controls if they had ≥1 diarrhea sample available for testing from the first year of life but all RT-PCR Ct values for astrovirus were ≥30.

Genotyping Array

In the PROVIDE study, children were genotyped on the Expanded Multi-Ethnic Genotyping Array (MEGA-EX) from Illumina, and those from the CBC study were genotyped on Illumina's Infinium Multiethnic Global Array (MEGA). These genetic data were phased with SHAPEIT software (version 2) and imputed with IMPUTE software (version 2.3.2) with 1000 Genomes Project phase 3 data as the reference. Standard quality control metrics were used for the genome-wide data. Single-nucleotide polymorphism (SNP) filters included genotype missingness <5%, minor allele frequency (MAF) >0.05, and Hardy-Weinberg equilibrium P > 10−5. The PROVIDE cohort had 10 792 283 initial variants, and the total genotyping rate was 0.99. A total of 590 340 variants were removed owing to missing genotype data, 1 487 431 were removed owing to minor allele threshold, and 131 were removed owing to Hardy-Weinberg exact test, leaving 8 777 081 variants.

In the CBC study, there were 10 942 212 initial variants and a total genotyping rate of 0.99. A total of 532 850 variants were lost owing to missing genotype data, 1 528 417 were removed owing to minor allele threshold, and 8 were removed owing to Hardy-Weinberg exact test, resulting in 8 880 118 variants that passed the quality control filters. Eighteen individuals in the CBC study were identified as outliers in the principal component analysis (PCA) based on their PCA score. Those with PCA scores falling 3 standard deviations above or below the median PCA value were removed (Supplementary Figure 2A and 2B). The genomic inflation factor, or λ, showed no inflation (λ=1.003 and 1.033 for PROVIDE and CBC studies, respectively) (Supplementary Figure 3).

Association Analysis

Genome-wide association analyses [18] using homo sapiens (human) genome assembly GRCh37 (hg19) from the Genome Reference Consortium were performed separately for each study, using logistic regression with an additive model within SNPTEST version 2. Manhattan plots were constructed for each cohort using the ggplot2 package in R software, version 3.6.1, and highlights of regions of interest were created using LocusZoom tools at locuszoom.org with hg19/1000 Genomes South Asian as the reference genome build.

Data from the PROVIDE and CBC studies were combined for a fixed-effects meta-analysis using METAL software [19]. Input from both cohorts was filtered on MAF >5% and IMPUTE2 (INFO) score >0.7, retaining SNPs that had been imputed with high certainty in the data set. Functional Mapping and Annotation of Genome-Wide Association Studies (FUMA) was used to annotate genomic regions of interest and identify variants in linkage disequilibrium [20]. This annotation included expression quantitative trait loci (eQTLs) from several databases, including the Genotype-Tissue Expression project (GTEx) and the eQTLGen Consortium [21]. Conditional analyses were performed at each associated locus using SNPTEST version 2 in each cohort and then combined for an overall fixed-effects meta-analysis with METAL software.

RESULTS

Within the PROVIDE study, 119 children were identified as having ≥1 astrovirus-associated diarrheal case in the first year of life, and 314 children did not have an associated astroviral infection. Children with astrovirus-associated diarrhea had a younger mean age (99.3 days) at the first diarrheal episode than children without astrovirus infection (123.6 days). Similarly, there were 58 case patients with astrovirus-associated diarrhea and 96 controls in the CBC study, with a mean age of first diarrheal episode of 117.7 days for case patients and 125.2 days for controls. In both cohorts, children not identified as case patients or controls either left the study early, did not have diarrhea, or had ≥1 sample with missing data for astrovirus. The distribution of HAZ and WAZ scores did not differ between case patients and controls in either cohort at birth or at 12 months of age (Table 1). Case patients and controls both had a mean mild diarrheal severity score in the PROVIDE study and a mean moderate diarrheal severity score in the CBC study (Table 1).

Table 1.

Characteristics of Children in Performance of Rotavirus and Oral Polio Vaccines in Developing Countries (PROVIDE) and Cryptosporidiosis and Enteropathogens in Bangladesh Birth Cohort (CBC) Studies

Characteristic Children in PROVIDE Study, No. (%)a Children in CBC Study, No. (%)a
Case Patients (n = 119) Controls (n = 314) Case Patients (n = 58) Controls (n = 96)
Age at first diarrheal infection, mean, d 99.3 123.6 117.7 125.2
Female sex 48 (40.3) 151 (48.1) 33 (56.9) 53 (55.2)
HAZ and WAZ scores at birth
 HAZ scores
  ≤−2 13 (11.0) 31 (9.9) 7 (12.1) 12 (12.5)
  −1.99 to ≤ 0 88 (74.0) 239 (76.1) 44 (75.9) 65 (67.7)
  >0 18 (15.1) 44 (14.0) 7 (12.1) 19 (19.8)
 WAZ scores
  ≤−2 24 (20.2) 65 (20.7) 14 (24.1) 21 (21.9)
  −1.99 to ≤ 0 85 (71.4) 231 (73.6) 38 (65.5) 71 (74.0)
  >0 10 (8.4) 18 (5.7) 6 (10.3) 4 (4.2)
HAZ and WAZ scores at 12 mo
 HAZ scores
  ≤−2 40 (33.9) 83 (27.0) 13 (22.4) 26 (27.1)
  −1.99 to ≤ 0 67 (56.8) 203 (66.1) 42 (72.4) 60 (62.5)
  >0 11 (9.3) 21 (6.8) 3 (5.2) 8 (8.3)
 WAZ scores
  ≤−2 33 (28.0) 68 (22.1) 9 (15.5) 19 (19.8)
  −1.99 to ≤ 0 69 (58.5) 190 (61.9) 34 (58.6) 63 (65.6)
  >0 16 (13.6) 49 (16.0) 15 (25.9) 12 (12.5)
Diarrheal severity: Ruuska score, mean 7.7 7.3 8.8 8.7
No. in household, mean 5.3 5.3 5.5 5.5
Principal source of household drinking water
 Municipality supply/piped water 114 (95.8) 305 (97.1) 58 (100) 95 (99.0)
 Own arrangement by pump 3 (2.5) 9 (2.9) 0 (0) 1 (1.0)
 Tube well 2 (1.7) 0 (0) 0 (0) 0 (0)
Principal type of toilet facility in household
 Septic tank or toilet 57 (47.9) 179 (57.0) 22 (37.9) 40 (41.7)
 VIP with water seal 0 (0) 0 (0) 7 (12.1) 21 (21.9)
 Water-sealed or slab latrine 52 (43.7) 121 (38.5) 27 (46.6) 34 (35.4)
 Pit, open, or hanging latrine 10 (8.4) 14 (4.5) 2 (3.4) 1 (1.0)
Toilet facility shared with other households
 Yes 103 (86.6) 268 (85.4) 39 (67.2) 70 (72.9)
 No 16 (13.4) 46 (14.6) 19 (32.8) 26 (27.1)
Household food availability
 Deficit all year 7 (5.9) 7 (2.2) 1 (1.7) 1 (1.0)
 Deficit sometimes 31 (26.1) 109 (34.7) 1 (1.7) 1 (1.0)
 Neither deficit nor surplus 55 (46.2) 132 (42.0) 11 (19.0) 14 (14.6)
 Surplus 26 (21.8) 66 (21.0) 45 (77.6) 80 (83.3)

Abbreviations: CBC, Cryptosporidiosis and Enteropathogens in Bangladesh Birth Cohort; HAZ, height-for-age z; PROVIDE, Performance of Rotavirus and Oral Polio Vaccines in Developing Countries; VIP, ventilated improved pit; WAZ, weight-for-age z.

aData represent no. (%) of children unless otherwise specified.

Genetic Associations

Figure 1 shows the association results for each cohort and the meta-analysis. The top association (rs75437404; meta-analysis P = 8.82 × 10−9; MAF, 16.7%) was identified in a noncoding region on chromosome 1 near the loricrin gene (LOR) (Table 2). The LOR gene is 2.4 kb in size, and the peak association region around this SNP spans 88 kb (Figure 2A) [22]. Children with ≥1 copy of the A allele at SNP rs75437404 were 2.7 times as likely to have an astrovirus-associated diarrheal infection within the first year of life as children with the T allele. This top associated SNP, rs75437404, has an MAF of 17.2% in the PROVIDE and 15.2% in the CBC study and is in linkage disequilibrium (r2 > 0.8), with 13 variants spanning an intergenic region 15.3 kb upstream of LOR. A conditional analysis incorporating rs75437404 in the model attenuated the association, suggesting that the region is in strong linkage disequilibrium and the alleles are correlated (Figure 2C).

Figure 1.

Figure 1.

Single-nucleotide polymorphism (SNP) associations with astrovirus-associated diarrhea in the first year of life. Manhattan plots show −log10  P values for SNP associations by cohort, and dashed lines indicate thresholds for genome-wide significance (5 × 10−7). A, Performance of Rotavirus and Oral Polio Vaccines in Developing Countries (PROVIDE) study. B, Cryptosporidiosis and Enteropathogens in Bangladesh Birth Cohort (CBC) study C, Meta-analysis.

Table 2.

Genome-wide Significant Associated Single-Nucleotide Polymorphism From Stratified Analyses and Meta-analysis

SNP/Variant Chromosome Position PROVIDE Study (n = 433) CBC Study (n = 154) Meta-analysis
OR MAF P Value OR MAF P Value OR 95% CI P Value
rs75437404 1 153 216 817 2.60 0.17 1.09 × 10−7 2.12 0.15 1.81 × 10−2 2.71 1.93–3.81 8.82 × 10−9
rs12131158 1 153 221 315 2.53 0.19 2.28 × 10−7 1.94 0.17 2.99 × 10−2 2.47 1.79–3.40 3.02 × 10−8
rs7518709 1 153 225 883 2.53 0.19 2.28 × 10−7 1.94 0.17 2.99 × 10−2 2.47 1.79–3.40 3.02 × 10−8
rs7542150 1 153 225 921 2.53 0.19 2.27 × 10−7 1.94 0.17 2.99 × 10−2 2.47 1.79–3.40 3.01 × 10−8
rs6666892 1 153 226 579 2.53 0.19 2.28 × 10−7 1.94 0.17 2.99 × 10−2 2.47 1.79–3.40 3.02 × 10−8
rs6661601 1 153 233 510 2.39 0.20 6.22 × 10−7 2.02 0.17 1.89 × 10−2 2.44 1.77–3.36 4.46 × 10−8
rs12408942 1 153 241 677 2.44 0.20 3.95 × 10−7 2.01 0.17 1.96 × 10−2 2.47 1.79–3.41 3.06 × 10−8
rs114810342 10 120 346 096 2.91 0.07 1.60 × 10−5 4.82 0.07 2.80 × 10−4 4.05 2.48–6.62 2.38 × 10−8
rs55907016 10 120 347 235 2.91 0.07 1.54 × 10−5 4.81 0.07 3.96 × 10−4 4.06 2.48–6.63 2.30 × 10−8
rs75935441 10 120 350 104 2.99 0.07 7.71 × 10−6 4.58 0.07 3.96 × 10−4 4.17 2.55–6.83 1.33 × 10−8
rs116216801 10 120 350 154 2.99 0.07 7.71 × 10−6 4.58 0.07 3.96 × 10−4 4.17 2.55–6.83 1.33 × 10−8
rs115109981 10 120 350 780 2.99 0.07 7.70 × 10−6 4.57 0.07 3.71 × 10−4 4.17 2.55–6.83 1.34 × 10−8
rs117647802 10 120 351 875 2.99 0.07 7.69 × 10−6 4.57 0.07 3.72 × 10−4 4.17 2.55–6.82 1.34 × 10−8
rs116989176 10 120 357 518 3.00 0.08 7.43 × 10−6 4.22 0.07 6.19 × 10−3 4.08 2.50–6.66 1.95 × 10−8
rs1711891 10 120 359 829 3.00 0.08 7.42 × 10−6 4.23 0.07 6.18 × 10−3 4.07 2.50–6.65 1.93 × 10−8

Abbreviations: CBC, Cryptosporidiosis and Enteropathogens in Bangladesh Birth Cohort; CI, confidence interval; MAF, minor allele frequency; OR, odds ratio; PROVIDE, Performance of Rotavirus and Oral Polio Vaccines in Developing Countries; SNP, single-nucleotide polymorphism.

Figure 2.

Figure 2.

Regional association plots for 2 meta-analysis loci. A, Chromosome 1: LOR region. B, Chromosome 10: PRLHR region. C, Chromosome 1: LOR region conditioning on rs75437404. D, Chromosome 10: PRLHR region conditioning on rs75935441.

We also identified another region, including the prolactin releasing hormone receptor gene (PRLHR). The peak association region around PRLHR spans 51 kb, including the 9.9-kb gene (Figure 2B) on chromosome 10 (Figure 1A, 1C) [22]. SNP rs75935441 is in the 3' untranslated region of the PRLHR gene (meta-analysis P = 1.33 × 10−8; MAF, 7.5%) and is part of an enhancer sequence [23]. Children with ≥1 copy of the C allele at rs75935441 were 4 times as likely to have an astrovirus diarrheal infection as children with the T allele (odds ratio [OR], 4.17 [95% confidence interval, 2.55–6.83]). The conditional analysis including rs75935441 in the model attenuated the signal (Figure 2D).

Using FUMA, we identified chromatin interactions with the promoter regions of 55 genes on chromosome 1, including LOR, PRR9, PGLYRP4, S100A9, and S100A12 (Figure 3A and Supplementary Table 1) spanning base pairs 153 181 362–153 242 630. Additionally, 11 genes had ≥1 eQTL in this region (Supplementary Table 2). Several variants have been previously associated with expression of multiple genes. For example, rs12125683 (C allele OR, 2.23, meta-analysis P = 7.92 × 10−7) is associated with expression of PGLYRP4, S100A12, and S100A9. The C allele of the SNP is associated with higher expression of PGLYRP4 in esophagus mucosa (P = 2.69 × 10−5), as well as higher expression of S100A12 (P = 1.94 × 10−23) and S100A9 (P = 1.27 × 10−6) in whole blood (Supplementary Table 2).

Figure 3.

Figure 3.

Circos plots of chromatin interactions. Outermost rings show results from the genome-wide association study meta-analysis for chromosomes 1 (A) and 10 (B). The next ring in each plot shows base pair coordinates along the chromosome (in megabases), with the region of interest colored blue. The innermost ring is annotated with gene symbols for all genes with a chromatin interaction (orange), an expression quantitative trait locus (green), or both (red).

Similarly, the chromosome 10 region (base pairs 120 252 606–120 359 829) had chromatin interactions with the promoter regions of 16 genes on chromosome 10, including PRLHR, CACUL1, KCNK18, ENO4, and EIF3A (Figure 3B, Supplementary Table 1). Only 1 gene also had identified eQTLs: CACUL1. The top associated SNP in this locus, rs75935441 (C allele OR, 4.17; meta-analysis P = 1.33 × 10−8), is an eQTL for CACUL1, and the C allele is associated with lower expression in both whole blood (P = 1.20 × 10−12) and skeletal muscle (P = 4.36 × 10−6) (Supplementary Table 2).

DISCUSSION

We identified 2 significant regions across the genome that were associated with astrovirus diarrheal infection in the first year of life. The first region is upstream of the LOR gene and is associated with expression of immune system genes PGLYRP4, S100A12, and S100A9. The second region encompasses the PLRHR gene and is associated with expression of the gene CACUL1.

LOR encodes loricrin, which contributes to the protective barrier function of the epidermis and is expressed almost exclusively in mammalian stratified epithelia [24]. It is also found in macrophages in various tissues [25], but the relationship to astrovirus is not evident. However, within the chromosome 1 locus, the presence of chromatin interactions coupled with identification of eQTLs indicates that several of these variants are likely regulatory in nature. Both S100A12 and S100A9 are in the “MyD88-dependent cascade initiated on endosome” SuperPath [22]. Astrovirus enters cells via endocytosis, and when Toll-like receptors (TLRs) bind viral nucleic acid inside the cell, they initiate signaling cascades which include MyD88 and type 1 interferon [26, 27]. The S100A9 protein regulates TLR3 activation [28, 29], and the S100A12 protein is an endogenous activator of TLR4 [30]. Both proteins are calgranulins and in addition to TLR activation are also involved in protecting the body against damage from inflammation [31, 32]. The same allele associated with higher expression of these genes in whole blood is associated with increased odds of astrovirus-positive diarrhea in the first year of life. The C allele of rs12125683 is also associated with higher expression of PGLYRP4 in esophagus mucosa. PGLYRP4 is a peptidoglycan recognition protein, involved in the innate immune response to bacteria [22]. Higher expression of this gene could contribute to astrovirus susceptibility via changes to the gastrointestinal microbiome [33].

The PRLHR gene is also in a region significantly associated with astrovirus diarrheal infections. This gene encodes the receptor for prolactin-releasing peptide, which has been identified as a target for obesity treatment [34]. In mouse and rat models, prolactin-releasing peptide influences feeding patterns and energy balance, and it has shown diet-suppressing effects [34, 35]. However, we further stratified by WAZ and HAZ scores to account for any underlying malnutrition at birth or at 12 months of age that may predispose an individual to an infection, and there were no differences between case patients and controls (Table 1). Thus, the association between PRLHR and astrovirus diarrhea infections is not likely to be mediated by malnutrition. Further investigation to identify the potential association between PRLHR and the astrovirus replication cycle or its pathogenic mechanism is warranted.

In addition to the effects on PRLHR, we found SNPs associated with increased risk of astrovirus-positive diarrhea that were also associated with lower expression of the gene CACUL1 in whole blood. This gene promotes cell proliferation and higher expression has been linked to increased invasion of gastric cancer cells [36]. While this gene is linked to Helicobacter pylori activity [36], it is unclear how it may be involved in astrovirus pathogenesis. Additional chromatin interactions at this locus suggest the potential for regulation of the genes ENO4, KCNK18, and EIF3A, but there are not yet data showing differences in gene expression based on genotypes found in the region of interest.

In conclusion, we identified 2 genetic regions associated with astrovirus infection susceptibility. Both regions warrant additional exploration for their potential association with immune and gastric cells and may elucidate astrovirus infection pathways.

Supplementary Material

ofae045_Supplementary_Data

Notes

Acknowledgments. We thank the families who participated in these studies, as well as the field research assistants and laboratory staff. The International Centre for Diarrhoeal Disease Research, Bangladesh is grateful to the governments of Bangladesh, Canada, Sweden, and the United Kingdom for their unrestricted core support.

Author contributions . R. H., W. A. P., and P. D. conceived and designed the study. R. H., A. J. M., B. D. K., and W. A. P. acquired data. R. H., U. N., A. J. M., B. D. K., G. L. W., W. A. P., and P. D. curated data. L. C., R. M. M., D. D., and P. D. analyzed and interpreted data, with assistance in interpretation from P. K., G. L. W., and W. A. P. All authors were responsible for writing the manuscript and approved the final version for publication.

Data availability . Data are publicly available from the National Institutes of Health's database of Genotypes and Phenotypes (dbGaP), accession phs001478.v1.p1 and phs001665.v1.p1, or by request from the authors.

Disclaimer. The funders had no role in study design, analysis, or publication.

Financial support . This work was supported by the Maryland Genetics, Epidemiology, and Medicine Training Program, funded by Burroughs-Wellcome Fund; the National Institute of Allergy and Infectious Disease (grants AI146123, AI043596, and AI026649); and the Bill & Melinda Gates Foundation (research grants to W.A.P.).

Contributor Information

Laura Chen, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Rebecca M Munday, Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Rashidul Haque, Emerging Infections & Parasitology Laboratory, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.

Dylan Duchen, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Uma Nayak, Center for Public Health Genomics, University of Virginia School of Medicine, Charlottesville, Virginia, USA; Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, Virginia, USA.

Poonum Korpe, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Alexander J Mentzer, The Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.

Beth D Kirkpatrick, Department of Microbiology and Molecular Genetics, Vaccine Testing Center, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA.

Genevieve L Wojcik, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

William A Petri, Jr., Department of Medicine, Infectious Diseases and International Health, University of Virginia School of Medicine, Charlottesville, Virginia, USA

Priya Duggal, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Supplementary Data

Supplementary materials are available at Open Forum Infectious Diseases online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author.

References

  • 1. World Health Organization . The top 10 causes of death 2020. Available at: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed 12 March 2023.
  • 2. World Health Organization . Diarrhoea 2023. Available at: https://www.who.int/health-topics/diarrhoea. Accessed 12 March 2023.
  • 3. Limaheluw  J, Medema  G, Hofstra  N. An exploration of the disease burden due to Cryptosporidium in consumed surface water for sub-Saharan Africa. Int J Hyg Environ Health  2019; 222:856–63. [DOI] [PubMed] [Google Scholar]
  • 4. Bosch  A, Pintó  RM, Guix  S. Human astroviruses. Clin Microbiol Rev  2014; 27:1048–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Schnee  AE, Haque  R, Taniuchi  M, et al.  Identification of etiology-specific diarrhea associated with linear growth faltering in Bangladeshi infants. Am J Epidemiol  2018; 187:2210–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Resque  HR, Munford  V, Castilho  JG, et al.  Molecular characterization of astrovirus in stool samples from children in São Paulo, Brazil. Mem Inst Oswaldo Cruz  2007; 102:969–74. [DOI] [PubMed] [Google Scholar]
  • 7. Kapusinszky  B, Minor  P, Delwart  E. Nearly constant shedding of diverse enteric viruses by two healthy infants. J Clin Microbiol  2012; 50:3427–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Chhabra  P, Payne  DC, Szilagyi  PG, et al.  Etiology of viral gastroenteritis in children <5 years of age in the United States, 2008–2009. J Infect Dis  2013; 208:790–800. [DOI] [PubMed] [Google Scholar]
  • 9. Meyer  CT, Bauer  IK, Antonio  M, et al.  Prevalence of classic, MLB-clade and VA-clade astroviruses in Kenya and The Gambia. Virol J  2015; 12:78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Vu  D-L, Bosch  A, Pintó  RM, Guix  S. Epidemiology of classic and novel human astrovirus: gastroenteritis and beyond. Viruses  2017; 9:33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Vu  DL, Cordey  S, Brito  F, Kaiser  L. Novel human astroviruses: novel human diseases?  J Clin Virol  2016; 82:56–63. [DOI] [PubMed] [Google Scholar]
  • 12. Kurtz  JB, Lee  TW, Craig  JW, Reed  SE. Astrovirus infection in volunteers. J Med Virol  1979; 3:221–30. [DOI] [PubMed] [Google Scholar]
  • 13. Abad  FX, Pintó  RM, Villena  C, et al.  Astrovirus survival in drinking water. Appl Environ Microbiol  1997; 63:3119–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Olortegui  MP, Rouhani  S, Yori  PP, et al.  Astrovirus infection and diarrhea in 8 countries. Pediatrics  2018; 141:e20171326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Kirkpatrick  BD, Colgate  ER, Mychaleckyj  JC, et al.  The “Performance of Rotavirus and Oral Polio Vaccines in Developing Countries” (PROVIDE) study: description of methods of an interventional study designed to explore complex biologic problems. Am J Trop Med Hyg  2015; 92:744–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Steiner  KL, Ahmed  S, Gilchrist  CA, et al.  Species of cryptosporidia causing subclinical infection associated with growth faltering in rural and urban Bangladesh: a birth cohort study. Clin Infect Dis  2018; 67:1347–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Liu  J, Gratz  J, Amour  C, et al.  A laboratory-developed TaqMan array card for simultaneous detection of 19 enteropathogens. J Clin Microbiol  2013; 51:472–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Uffelmann  E, Huang  QQ, Munung  NS, et al.  Genome-wide association studies. Nat Rev Methods Primer  2021; 1:1–21. [Google Scholar]
  • 19. Willer  CJ, Li  Y, Abecasis  GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics  2010; 26:2190–1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Watanabe  K, Taskesen  E, van Bochoven  A, Posthuma  D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun  2017; 8:1826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Võsa  U, Claringbould  A, Westra  HJ, et al.  Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet  2021; 53:1300–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Stelzer  G, Rosen  N, Plaschkes  I, et al.  The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinforma  2016; 54:1.30.1–1.30.33. [DOI] [PubMed] [Google Scholar]
  • 23. Zerbino  DR, Wilder  SP, Johnson  N, et al.  The Ensembl Regulatory Build. Genome Biol  2015; 16:56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Hohl  D, Lichti  U, Breitkreutz  D, et al.  Transcription of the human loricrin gene in vitro is induced by calcium and cell density and suppressed by retinoic acid. J Invest Dermatol  1991; 96:414–8. [DOI] [PubMed] [Google Scholar]
  • 25. Uhlén  M, Fagerberg  L, Hallström  BM, et al.  Proteomics: tissue-based map of the human proteome. Science  2015; 347:1260419. [DOI] [PubMed] [Google Scholar]
  • 26. Lester  SN, Li  K. Toll-like receptors in antiviral innate immunity. J Mol Biol  2014; 426:1246–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Marvin  SA. The immune response to astrovirus infection. Viruses  2016; 9:1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Tsai  S-Y, Segovia  JA, Chang  TH, et al.  DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation during influenza A virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway. PLOS Pathog  2014; 10:e1003848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Tsai  S-Y, Segovia  JA, Chang  T-H, et al.  Regulation of Toll-like receptor 3 activation by S100A9. J Immunol Baltim Md 1950  2015; 195:4426–37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Kessel  C, Fühner  S, Brockmeyer  S, et al.  Hexameric S100A12 is required for pro-inflammatory TLR4-signalling. Pediatr Rheumatol Online J  2015; 13:O30. [Google Scholar]
  • 31. Hsu  K, Champaiboon  C, Guenther  BD, et al.  Anti-infective protective properties of S100 calgranulins. Anti-Inflamm Anti-Allergy Agents Med Chem  2009; 8:290–305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Jukic  A, Bakiri  L, Wagner  EF, et al.  Calprotectin: from biomarker to biological function. Gut  2021; 70:1978–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Dabrowski  AN, Shrivastav  A, Conrad  C, et al.  Peptidoglycan recognition protein 4 limits bacterial clearance and inflammation in lungs by control of the gut microbiota. Front Immunol  2019; 10:2106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Kuneš  J, Pražienková  V, Popelová  A, et al.  Prolactin-releasing peptide: a new tool for obesity treatment. J Endocrinol  2016; 230:R51–58. [DOI] [PubMed] [Google Scholar]
  • 35. Mikulášková  B, Zemenová  J, Pirník  Z, et al.  Effect of palmitoylated prolactin-releasing peptide on food intake and neural activation after different routes of peripheral administration in rats. Peptides  2016; 75:109–17. [DOI] [PubMed] [Google Scholar]
  • 36. Kong  Y, Ma  L, Bai  P, et al.  Helicobacter pylori promotes invasion and metastasis of gastric cancer cells through activation of AP-1 and up-regulation of CACUL1. Int J Biochem Cell Biol  2013; 45:2666–78. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ofae045_Supplementary_Data

Articles from Open Forum Infectious Diseases are provided here courtesy of Oxford University Press

RESOURCES